Trial Profile
A Proof Of Concept Study To Evaluate Tiotropium as Add-on Therapy to Inhaled Budesonide/Formoterol Combination in COPD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2016
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Budesonide/formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 22 Oct 2009 New trial record